Egr-1 is required for neu/HER2-induced mammary tumors-Reference-Cited by-同舟云学术

Egr-1 is required for neu/HER2-induced mammary tumors

Published:2018-05 Issue: Volume:45 Page:102-109
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Oh Sunhwa,Kim Hyungjoo,Nam KeeSoo,Shin Incheol

Funder

Korea Research Foundation

Ministry of Science & ICT

Publisher

Elsevier BV

Subject

Cell Biology

Reference49 articles.

1. The Egr transcription factor family: from signal transduction to kidney differentiation;Sukhatme;Kidney Int.,1992

2. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1;Liu;Proc. Natl. Acad. Sci. U. S. A.,1996

3. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling;Virolle;Nat. Cell Biol.,2001

4. Tumor proliferative compartment, multidrug resistance gene product and apoptosis regulatory p53 and bcl-2 proteins in pediatric acute lymphoblastic leukemia;Srinivas;Oncol. Rep.,1997

5. The transcription factor EGR-1 directly transactivates the fibronectin gene and enhances attachment of human glioblastoma cell line U251;Liu;J. Biol. Chem.,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early growth response 1 regulates dual‑specificity protein phosphatase 1 and inhibits cell migration and invasion of tongue squamous cell carcinoma;Oncology Letters;2024-04-03

2. Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development; and their Therapeutic Applications in Cancers - A Narrative Review;Journal of Pharmacy and Nutrition Sciences;2022-12-13

3. Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review;International Journal of Molecular Sciences;2022-06-28

4. Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib;Cancer Management and Research;2018-08